Analysts expect AgomAb Therapeutics NV to report revenue of 454,675.79 for 2026, against a range of 427,470.72 to 481,880.86. The most recent reported year, 2025, came in at 0.00, a 100.0% miss against the 684,665.23 consensus.
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | - | - | ||
| High Estimate | 746,378.90 | 481,880.86 | 614,582.59 | ||
| Low Estimate | 622,951.56 | 427,470.72 | 514,407.31 | ||
| Consensus Estimate | 684,665.23 | 454,675.79 | 564,494.95 |
Analysts expect AgomAb Therapeutics NV to report earnings per share of -1.87 for 2026, against a range of -1.94 to -1.80. The most recent reported year, 2025, came in at -168.21 , in line with the -2.18 consensus.
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Reported (Actual) | -168.21 | - | - | ||
| High Estimate | -2.05 | -1.80 | -2.02 | ||
| Low Estimate | -2.31 | -1.94 | -2.26 | ||
| Consensus Estimate | -2.18 | -1.87 | -2.14 |
Pull Wall Street consensus for AgomAb Therapeutics NV (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AGMB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AGMB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AGMB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();